Publication | Closed Access

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

Cell TherapyTransplantationCmv DiseaseHematologyImmunologyStem Cell TransplantationVirologyGraft SurvivalChronic Viral InfectionMedicineCell TransplantationRefractory CytomegalovirusHigh Risk